AURO-SITAGLIPTIN

auro pharma inc🇨🇦 Health Canada

Approval Id: 853dc126c7e55078
Drug Approval Canada Name: AURO-SITAGLIPTIN
Product Name: AURO-SITAGLIPTIN
Status: Marketed
Status Date: 2023-01-05
Original Market Date: 2023-01-05
Din: 02529882
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:20.05
Atc Original: A10BH01 SITAGLIPTIN
Atc Name: a 10 bh 01
Aig Number: 0152414001
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

SITAGLIPTIN (SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE)

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

853dc126c7e55078

Type

Standard